Perseus Biomics (Private limited company)
Perseus Biomics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0650.946.412. It was founded on 31-03-2016. Its registered office is in Leuven. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 2 057 143 and a loss of € 2 463 978. These accounts report 14.3 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 10-10-2026.
Company information
Key figures of Perseus Biomics
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -2 463 978-16 % | € -2 127 963-5 % | € -2 032 346-69 % | € -1 201 563 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 2 057 143-54 % | € 4 521 121-3 % | € 4 649 084+13 733 % | € 33 609 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 5 245 845-4 % | € 5 465 030+4 % | € 5 264 187+22 % | € 4 304 081 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 320 026-46 % | € 593 692+25 % | € 475 363+38 % | € 344 097 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 14.3-16 % | 17.1+12 % | 15.3+25 % | 12.2 |
Financial estimate
- 2 Subsidiaries
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| SOUND & SILENCE | 3001 Leuven |
| Formac Pharmaceuticals | 3001 Leuven |
| FOCUS PHARMA | 3001 Leuven |
| Raya Therapeutic | 3001 Leuven |
| RheADC | 3001 Leuven |
| COULTREON BIOPHARMA | 3001 Leuven |
| Open Alzheimer | 3001 Leuven |
| Lever Bio Belgium | 3001 Leuven |
Frequently asked questions
Is Perseus Biomics still active? Yes. The Crossroads Bank for Enterprises lists Perseus Biomics as active.
What is the VAT number of Perseus Biomics? The VAT number of Perseus Biomics is BE 0650.946.412.
When was Perseus Biomics founded? Perseus Biomics was founded on 31-03-2016.
What is the address of Perseus Biomics? The current registered office of Perseus Biomics is Gaston Geenslaan 3, 3001 Louvain.
When did Perseus Biomics last file annual accounts? The latest annual accounts of Perseus Biomics were filed on 29-07-2026.
Does Perseus Biomics file its annual accounts on time? Yes. Perseus Biomics filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does Perseus Biomics have? Perseus Biomics employs 14.3 full-time equivalents according to its most recent annual accounts.
Is Perseus Biomics financially healthy? Addrly gives Perseus Biomics a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Perseus Biomics profitable? The annual accounts of Perseus Biomics for 2025 show a loss of € 2 463 978.
What is the equity of Perseus Biomics? The equity of Perseus Biomics was € 2 057 143 at the close of the 2025 financial year.
Who are the directors of Perseus Biomics? The annual accounts of Perseus Biomics record 10 mandates. The names, roles and dates are visible with a free account.
Can Perseus Biomics receive Peppol e-invoices? Yes. Perseus Biomics is registered on the Peppol network and can receive structured electronic invoices.
What does Perseus Biomics do? The main activity of Perseus Biomics is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.